Question 1

What are the potential benefits of participating in this trial for my Type 1 Diabetes?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Siplizumab in T1DM clinical trial (NCT05574335). Contact the study team or your healthcare provider for specific answers.

Question 2

How does siplizumab compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Siplizumab in T1DM clinical trial (NCT05574335). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from siplizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Siplizumab in T1DM clinical trial (NCT05574335). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Siplizumab in T1DM clinical trial (NCT05574335). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will I need to undergo while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Siplizumab in T1DM clinical trial (NCT05574335). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my health be monitored after the treatment ends?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Siplizumab in T1DM clinical trial (NCT05574335). Contact the study team or your healthcare provider for specific answers.

What this study is about